Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 18341617)

1.

A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action.

MacDonald AJ, Libri NA, Lustigman S, Barker SJ, Whelan MA, Semper AE, Rosenberg WM.

Clin Exp Immunol. 2008 May;152(2):265-73. doi: 10.1111/j.1365-2249.2008.03623.x. Epub 2008 Mar 12.

2.

Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.

MacDonald AJ, Tawe W, Leon O, Cao L, Liu J, Oksov Y, Abraham D, Lustigman S.

Parasite Immunol. 2004 Jan;26(1):53-62.

PMID:
15198646
3.

Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells.

He Y, Barker SJ, MacDonald AJ, Yu Y, Cao L, Li J, Parhar R, Heck S, Hartmann S, Golenbock DT, Jiang S, Libri NA, Semper AE, Rosenberg WM, Lustigman S.

J Immunol. 2009 Apr 1;182(7):4005-16. doi: 10.4049/jimmunol.0800531.

5.

Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.

Schupper H, Hayashi P, Scheffel J, Aceituno S, Paglieroni T, Holland PV, Zeldis JB.

Hepatology. 1993 Nov;18(5):1055-60.

PMID:
7693570
6.

Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C.

Lechmann M, Woitas RP, Langhans B, Kaiser R, Ihlenfeldt HG, Jung G, Sauerbruch T, Spengler U.

J Hepatol. 1999 Dec;31(6):971-8.

PMID:
10604568
7.

The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates.

Wang J, Tricoche N, Du L, Hunter M, Zhan B, Goud G, Didier ES, Liu J, Lu L, Marx PA, Jiang S, Lustigman S.

PLoS One. 2012;7(5):e37019. doi: 10.1371/journal.pone.0037019. Epub 2012 May 17.

8.

Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.

Semmo N, Krashias G, Willberg C, Klenerman P.

J Viral Hepat. 2007 Jul;14(7):492-502.

PMID:
17576391
9.

Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals.

Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, Grant M.

BMC Immunol. 2008 Jun 13;9:28. doi: 10.1186/1471-2172-9-28.

11.

Impact of HIV on host-virus interactions during early hepatitis C virus infection.

Danta M, Semmo N, Fabris P, Brown D, Pybus OG, Sabin CA, Bhagani S, Emery VC, Dusheiko GM, Klenerman P.

J Infect Dis. 2008 Jun 1;197(11):1558-66. doi: 10.1086/587843.

12.

Effect of IL-12 on T-cell immune responses in patients with chronic HCV infection.

Fan XG, Tang FQ, Yi H, Liu WE, Houghton M, Hu GL.

APMIS. 2000 Jul-Aug;108(7-8):531-8.

PMID:
11167550
13.

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.

Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG.

Gut. 2008 Aug;57(8):1121-8. doi: 10.1136/gut.2007.130963. Epub 2008 Mar 27.

PMID:
18372499
14.

Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.

Gigi E, Raptopoulou-Gigi M, Kalogeridis A, Masiou S, Orphanou E, Vrettou E, Lalla TH, Sinakos E, Tsapas V.

J Viral Hepat. 2008 Feb;15(2):145-54. doi: 10.1111/j.1365-2893.2007.00908.x.

PMID:
18184198
15.
16.

Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.

Pfaff AW, Kirch AK, Hoffmann WH, Banla M, Schulz-Key H, Geiger SM, Soboslay PT.

Parasite Immunol. 2003 Jun;25(6):325-32.

PMID:
14507330
18.

Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.

Cooper PJ, Mancero T, Espinel M, Sandoval C, Lovato R, Guderian RH, Nutman TB.

J Infect Dis. 2001 Jun 1;183(11):1662-8. Epub 2001 Apr 27.

19.

HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.

Ruys TA, Nanlohy NM, van den Berg CH, Hassink E, Beld M, van de Laar T, Bruisten S, Wit F, Krol A, Prins M, Lange J, van Baarle D.

J Viral Hepat. 2008 Jun;15(6):409-20. doi: 10.1111/j.1365-2893.2007.00963.x. Epub 2008 Jan 22.

PMID:
18221302
20.

Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection.

Inoue M, Kanto T, Miyatake H, Itose I, Miyazaki M, Yakushijin T, Sakakibara M, Kuzushita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.

J Hepatol. 2006 Aug;45(2):190-6. Epub 2006 Feb 28.

PMID:
16580086
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk